Inflammasomes

Cold Spring Harbor Perspectives in Biology

Volumn 6, Issue 12, 2014, Pages

  de Zoete, Marcel R ^a   Palm, Noah W ^a   Zhu, Shu ^a   Flave, Richard A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIM2 PROTEIN, HUMAN; APOPTOSIS REGULATORY PROTEIN; CALCIUM BINDING PROTEIN; CARRIER PROTEIN; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; DNA BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA CONVERTING ENZYME; NLRC4 PROTEIN, HUMAN; NLRP1 PROTEIN, HUMAN; NLRP3 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

BIOLOGICAL MODEL; CHRONIC DISEASE; DENDRITIC CELL; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROFLORA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS REGULATORY PROTEINS; CALCIUM-BINDING PROTEINS; CARD SIGNALING ADAPTOR PROTEINS; CARRIER PROTEINS; CASPASE 1; CHRONIC DISEASE; DENDRITIC CELLS; DNA-BINDING PROTEINS; HUMANS; INFLAMMASOMES; INFLAMMATION; MICROBIOTA; MODELS, IMMUNOLOGICAL;

EID: 84919344269     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a016287     Document Type: Article

References (225)

1. Abdullah Z, Schlee M, Roth S, Mraheil MA, Barchet W, Bottcher J, Hain T, Geiger S, Hayakawa Y, Fritz JH, et al. 2012. RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids. EMBO J 31: 4153-4164.
2. Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, Stein L, Russo R, Goldsmith D, Dent P, et al. 2002. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 46: 3340-3348.
3. Ali SR, Timmer AM, Bilgrami S, Park EJ, Eckmann L, Nizet V, Karin M. 2011. Anthrax toxin induces macrophage death by p38 MAPK inhibition but leads to inflammasome activation via ATP leakage. Immunity 35: 34-44.
4. Alipour M, Lou Y, Zimmerman D, Bording-Jorgensen MW, Sergi C, Liu JJ, Wine E. 2013. A balanced IL-1 b activity is required for host response to Citrobacter rodentium infection. PLoS ONE 8: e80656.
5. Alkhateeb A, Jarun Y, Tashtoush R. 2013. Polymorphisms in NLRP1 gene and susceptibility to autoimmune thyroid disease. Autoimmunity 46: 215-221.
6. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, Guthrie EH, Pickles RJ, Ting JP. 2009. The NLRP3 inflammasome mediates in vivo innate immunity to influenza Avirus through recognition of viral RNA. Immunity 30: 556-565.
7. Allen IC, Jania CM, Wilson JE, Tekeppe EM, Hua X, Brickey WJ, Kwan M, Koller BH, Tilley SL, Ting JP. 2012a. Analysis of NLRP3 in the development of allergic airway disease in mice. J Immunol 188: 2884-2893.
8. Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, Woodford RM, Davis BK, Uronis JM, Herfarth HH, et al. 2012b. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-kB signaling. Immunity 36: 742-754.
9. Amer A, Franchi L, Kanneganti TD, Body-Malapel M, Ozo-ren N, Brady G, Meshinchi S, Jagirdar R, Gewirtz A, Akira S, et al. 2006. Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf. J Biol Chem 281: 35217-35223.
10. Anand PK, Kanneganti TD. 2013. NLRP6 in infection and inflammation. Microbes Infect 15: 661-668.
11. Arlehamn CS, Petrilli V, Gross O, Tschopp J, Evans TJ. 2010. The role of potassium in inflammasome activation by bacteria. JBiol Chem 285: 10508-10518.
12. Ather JL, Ckless K, Martin R, Foley KL, Suratt BT, Boyson JE, Fitzgerald KA, Flavell R., Eisenbarth SC, Poynter ME. Serum amyloid A activates the NLRP3 inflamma-some and promotes Th17 allergic asthma in mice. J Immunol 187: 64-63.
13. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDon-ald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, et al. 2009. Cutting edge: NF-kB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183: 787-791.
14. Bauernfeind F, Bartok E, Rieger A, Franchi L, Nunez G, Hornung V. 2011. Cutting edge: Reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J Immunol 187: 613-617.
15. Boni-Schnetzler M, Donath MY 2013. How biologics targeting the IL-1 system are being considered for the treatment of type 2 diabetes. Br J Clin Pharmacol 76:263-268.
16. Boyden ED, Dietrich WF. 2006. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 38: 240-244.
17. Brodsky IE, Palm NW, Sadanand S, Ryndak MB, Sutterwala FS, Flavell R., Bliska JB, Medzhitov R. 2010. A Yersinia effector protein promotes virulence by preventing in-flammasome recognition of the type III secretion system. Cell Host Microbe 7: 376-387.
18. Broz P, Newton K, Lamkanfi M, Mariathasan S, Dixit VM, Monack DM. 2010. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med 207: 1745-1755.
19. Broz P, Ruby T, Belhocine K, Bouley DM, Kayagaki N, Dixit VM, Monack DM. 2012. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 490: 288-291.
20. Brunette RL, Young JM, Whitley DG, Brodsky IE, Malik HS, Stetson DB. 2012. Extensive evolutionary and functional diversity among mammalian AIM2-like receptors. J Exp Med 209: 1969-1983.
21. Brydges SD, Broderick L, McGeough MD, Pena CA, Mueller JL, Hoffman HM. 2013. Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies. J Clin Invest 123: 4695-4705.
22. Burdette D, Haskett A, Presser L, McRae S, Iqbal J, Waris G. Hepatitis C virus activates interleukin-1 b via cas-pase-1-inflammasome complex. J Gen Virol 93:235-246.
23. Carvalho FA, Nalbantoglu I, Aitken JD, Uchiyama R, Su Y, Doho GH, Vijay-Kumar M, Gewirtz AT. 2012. Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges. Mucosal Immunol 5: 288-298.
24. Case CL, Shin S, Roy CR. 2009. Asc and Ipaf Inflamma-somes direct distinct pathways for caspase-1 activation in response to Legionella pneumophila. Infect Immun 77: 1981-1991.
25. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell R., Sutterwala FS. 2008. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci 105: 9035-9040.
26. Ceballos-Olvera I, Sahoo M, Miller MA, Del Barrio L, Re F. 2011. Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1b is deleterious. PLoS Pathog 7: e1002452.
27. Chavarria-Smith J, Vance RE. 2013. Direct proteolytic cleavage of NLRP1B is necessary and sufficient for inflamma-some activation by anthrax lethal factor. PLoS Pathog 9: e1003452.
28. Chen GY, Liu M, Wang F, Bertin J, Nunez G. 2011. A functional role for Nlrp6 in intestinal inflammation and tu-morigenesis. J Immunol 186: 7187-7194.
29. Chi H, Messas E, Levine RA, Graves DT, Amar S. 2004. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: Phar-macotherapeutic implications. Circulation 110: 1678-1685.
30. Choubey D. 2012. DNA-responsive inflammasomes and their regulators in autoimmunity. Clin Immunol 142: 223-231.
31. Cui J, Zhu L, Xia X, Wang HY, Legras X, Hong J, Ji J, Shen P, Zheng S, Chen ZJ, et al. 2010. NLRC5 negatively regulates the NF-kB and type I interferon signaling pathways. Cell 141: 483-496.
32. Dai X, Sayama K, Tohyama M, Shirakata Y, Hanakawa Y, Tokumaru S, Yang L, Hirakawa S, Hashimoto K. 2011. Mite allergen is a danger signal for the skin via activation of inflammasome in keratinocytes. J Allergy Clin Immunol 127: 806-814.
33. Denoble AE, Huffman KM, Stabler TV, Kelly SJ, Hershfield MS, McDaniel GE, Coleman RE, Kraus VB. 2011. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci 108: 2088-2093.
34. de Zoete MR, Flavell RA. 2013. Interactions between Nodlike receptors and intestinal bacteria. Front Immunol 4: 462.
35. Dieude P, Guedj M, Wipff J, Ruiz B, Riemekasten G, Airo P, Melchers I, Hachulla E, Cerinic MM, Diot E, et al. 2011. NLRP1 influences the systemic sclerosis phenotype: A new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis 70: 668-674.
36. Dinarello CA, Simon A, van der Meer JW. 2012. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 11: 633-652.
37. Doitsh G, Galloway NL, Geng X, Yang Z, Monroe KM, Ze-peda O, Hunt PW, Hatano H, Sowinski S, Munoz-Arias I, et al. 2014. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505: 509-514.
38. Dombrowski Y, Peric M, Koglin S, Kammerbauer C, Goss C, Anz D, Simanski M, Glaser R, Harder J, Hornung V, et al. 2011. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med 3: 82ra38.
39. Dombrowski Y, Peric M, Koglin S, Kaymakanov N, Schmezer V, Reinholz M, Ruzicka T, Schauber J. 2012. Honey bee (Apis mellifera) venom induces AIM2 inflam-masome activation in human keratinocytes. Allergy 67: 1400-1407.
40. Dorhoi A, Nouailles G, Jorg S, Hagens K, Heinemann E, Pradl L, Oberbeck-Muller D, Duque-Correa MA, Reece ST, Ruland J, et al. 2012. Activation of the NLRP3 inflam-masome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis. Eur J Immunol 42: 374-384.
41. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320: 674-677.
42. Dostert C, Guarda G, Romero JF, Menu P, Gross O, Tardivel A, Suva ML, Stehle JC, Kopf M, Stamenkovic I, et al. 2009. Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS ONE 4: e6510.
43. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, et al. 2010. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357-1361.
44. Duncan JA, Gao X, Huang MT, O'Connor BP, Thomas CE, Willingham SB, Bergstralh DT, Jarvis GA, Sparling PF, Ting JP. 2009. Neisseria gonorrhoeae activates the protein-ase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J Immunol 182: 6460-6469.
45. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA. 2008. Crucial role for the Nalp3 inflamma-some in the immunostimulatory properties of aluminium adjuvants. Nature 453: 1122-1126.
46. Eisenbarth SC, Williams A, Colegio OR, Meng H, Strowig T, Rongvaux A, Henao-Mejia J, Thaiss CA, Joly S, Gonzalez DG, et al. 2012. NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells. Nature 484: 510-513.
47. Elhage R, Maret A, Pieraggi MT, Thiers JC, Arnal JF, Bayard F. 1998. Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation 97: 242-244.
48. Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon JI, et al. 2011. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145: 745-757.
49. Faustin B, Lartigue L, Bruey JM, Luciano F, Sergienko E, Bailly-Maitre B, Volkmann N, Hanein D, Rouiller I, Reed JC. 2007. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell 25: 713-724.
50. Feldmann J, Prieur AM, Quartier P, Berquin P, Certain S, Cortis E, Teillac-Hamel D, Fischer A, de Saint Basile G. 2002. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chon-drocytes. Am J Hum Genet 71: 198-203.
51. Fernandes-Alnemri T, Yu JW, Juliana C, Solorzano L, Kang S, Wu J, Datta P, McCormick M, Huang L, McDermott E, et al. 2010. The AIM2 inflammasome is critical for innate immunityto Francisella tularensis. NatImmunol 11: 385-393.
52. Fink SL, Bergsbaken T, Cookson BT. 2008. Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Proc Natl Acad Sci 105: 4312-4317.
53. Franchi L, Nunez G. 2008. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1 b secretion but dispensable for adjuvant activity. Eur JImmunol 38: 2085-2089.
54. Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozo-ren N, Jagirdar R, Inohara N, Vandenabeele P, Bertin J, Coyle A, et al. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1 b in salmonella-infected macrophages. Nat Immunol 7: 576-582.
55. Franchi L, Kanneganti TD, Dubyak GR, Nunez G. 2007. Differential requirement of P2X7 receptor and intracel-lular K+ for caspase-1 activation induced by intracellular and extracellular bacteria. J Biol Chem 282: 18810-18818.
56. Franchi L, Munoz-Planillo R, Nunez G. 2012. Sensing and reacting to microbes through the inflammasomes. Nat Immunol 13: 325-332.
57. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A. 2009. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5: 439-449.
58. Gage J, Hasu M, Thabet M, Whitman SC. 2012. Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice. Can J Cardiol 28: 222-229.
59. Garlanda C, Dinarello CA, Mantovani A. 2013. The inter-leukin-1 family: Back to the future. Immunity 39: 1003-1018.
60. Gasse P, Riteau N, Charron S, Girre S, Fick L, Petrilli V, Tschopp J, Lagente V, Quesniaux VF, Ryffel B, et al. 2009. Uric acid is a danger signal activating NALP3 in-flammasome in lung injury inflammation and fibrosis. Am JRespir Crit Care Med 179: 903-913.
61. Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, Kim HJ, Brewer C, Zalewski C, Wiggs E, et al. 2006. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1 b inhibition. N Engl J Med 355: 581-592.
62. Grebe A, Latz E. 2013. Cholesterol crystals and inflammation. Curr Rheum Rep 15: 313.
63. Gregory SM, Davis BK, West JA, Taxman DJ, Matsuzawa S, Reed JC, Ting JP, Damania B. 2011. Discovery of a viral NLR homolog that inhibits the inflammasome. Science 331: 330-334.
64. Grenier JM, Wang L, Manji GA, Huang WJ, Al-Garawi A, Kelly R, Carlson A, Merriam S, Lora JM, Briskin M, et al. 2002. Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kB and caspase-1. FEBS Lett 530: 73-78.
65. Gris D, Ye Z, Iocca HA, Wen H, Craven RR, Gris P, Huang M, Schneider M, Miller SD, Ting JP. 2010. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J Immunol 185: 974-981.
66. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschlager N, Endres S, Hartmann G, Tardivel A, Schweighoffer E, Tybulewicz V, et al. 2009. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459: 433-436.
67. Guarda G, Zenger M, Yazdi AS, Schroder K, Ferrero I, Menu P, Tardivel A, Mattmann C, Tschopp J. 2011. Differential expression of NLRP3 among hematopoietic cells. J Immunol 186: 2529-2534.
68. Gurcel L, Abrami L, Girardin S, Tschopp J, van der Goot FG. 2006. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126: 1135-1145.
69. Gurung P, Malireddi RK, Anand PK, Demon D, Vande Walle L, Liu Z, Vogel P, Lamkanfi M, Kanneganti TD. 2012a. Toll or interleukin-1 receptor (TIR) domain-containing adaptor inducing interferon-b (TRIF)-mediated cas-pase-11 protease production integrates toll-like receptor 4 (TLR4) protein and Nlrp3 inflammasome-mediated host defense against enteropathogens. J Biol Chem 287: 34474-34483.
70. Gurung P, Malireddi RS, Anand PK, Demon D, Walle LV, Liu Z, Vogel P, Lamkanfi M, Kanneganti T-D. 2012b. Toll or interleukin-1 receptor (TIR) domain-containing adaptor inducing interferon-b (TRIF)-mediated cas-pase-11 protease production integrates Toll-like receptor 4 (TLR4) protein-and Nlrp3 inflammasome-mediated host defense against enteropathogens. J Biol Chem 287: 34474-34483.
71. Hafner-Bratkovic I, Bencina M, Fitzgerald KA, Golenbock Jerala R. 2012. NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1 b and neuronal toxicity. Cell Mol Life Sci 69: 4215-4228.
72. Hagar JA, Powell DA, Aachoui Y, Ernst RK, Miao EA. 2013. Cytoplasmic LPS activates caspase-11: Implications in TLR4-independent endotoxic shock. Science 341: 1250-1253.
73. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golen-bock DT. 2008. The NALP3 inflammasome is involved in the innate immune response to amyloid-b. NatImmunol 9: 857-865.
74. He X, Mekasha S, Mavrogiorgos N, Fitzgerald KA, Lien Ingalls RR. 2010. Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome. J Immunol 184: 5743-5754.
75. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, et al. 2012. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482: 179-185.
76. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, Fitzgerald KA. 2009. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5: 487-497.
77. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Ko-lodner RD. 2001. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoin-flammatory syndrome and Muckle-Wells syndrome. Nat Genet 29: 301-305.
78. Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, Anderson JP, Wanderer AA, Firestein GS. 2004. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleu-kin-1 receptor antagonist. Lancet 364: 1779-1785.
79. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9: 847-856.
80. Hu B, Elinav E, Huber S, Strowig T, Hao L, Hafemann A, Jin C, Wunderlich C, Wunderlich T, Eisenbarth SC, et al. 2013. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc Natl Acad Sci 110: 9862-9867.
81. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A. 2009. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 206: 79-87.
82. Ichinohe T, Pang IK, Iwasaki A. 2010. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol 11: 404-410.
83. Ireton RC, Gale M Jr, 2011. RIG-I like receptors in antiviral immunity and therapeutic applications. Viruses 3: 906-919.
84. Ito M, Yanagi Y, Ichinohe T. 2012. Encephalomyocarditis virus viroporin 2B activates NLRP3 inflammasome. PLoS Pathog 8: e1002857.
85. Iyer SS, Pulskens WP, Sadler JJ, Butter LM, Teske GJ, Ulland TK, Eisenbarth SC, Florquin S, Flavell R., Leemans JC, et al. 2009. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci 106: 20388-20393.
86. Iyer SS, He Q, Janczy JR, Elliott EI, Zhong Z, Olivier AK, Sadler JJ, Knepper-Adrian V, Han R, Qiao L, et al. 2013. Mitochondrial cardiolipin is required for Nlrp3 inflam-masome activation. Immunity 39: 311-323.
87. Jesus AA, Goldbach-Mansky R. 2014. IL-1 blockade in autoinflammatory syndromes. Annu Rev Med 65: 223-244.
88. Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA. 2007. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 356: 1216-1225.
89. Jin C, Frayssinet P, Pelker R, Cwirka D, Hu B, Vignery A, Eisenbarth SC, Flavell RA. 2011. NLRP3 inflammasome plays a critical role in the pathogenesis ofhydroxyapatite-associated arthropathy. Proc Natl Acad Sci 108: 14867-14872.
90. Jin T, Perry A, Jiang J, Smith P, Curry JA, Unterholzner L, Jiang Z, Horvath G, Rathinam VA, Johnstone RW, et al. 2012. Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity 36: 561-571.
91. Jin T, Perry A, Smith P, Jiang J, Xiao TS. 2013. Structure of the absent in melanoma 2 (AIM2) pyrin domain provides insights into the mechanisms of AIM2 autoin-hibition and inflammasome assembly. J Biol Chem 288: 13225-13235.
92. Johnson KE, Chikoti L, Chandran B. 2013. Herpes simplex virus 1 infection induces activation and subsequent inhibition of the IFI16 and NLRP3 inflammasomes. J Virol 87: 5005-5018.
93. Joly S, Ma N, Sadler JJ, Soll DR, Cassel SL, Sutterwala FS. 2009. Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. JImmunol 183: 3578-3581.
94. Jones JW, Kayagaki N, Broz P, Henry T, Newton K, O'Rourke K, Chan S, Dong J, Qu Y, Roose-Girma M, et al. 2010. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc Natl Acad Sci 107: 9771-9776.
95. Jourdan T, Godlewski G, Cinar R, Bertola A, Szanda G, Liu J, Tam J, Han T, Mukhopadhyay B, Skarulis MC, et al. 2013. Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates b cell loss in type 2 diabetes. Nat Med 19: 1132-1140.
96. Kanneganti TD, Body-Malapel M, Amer A, Park JH, Whitfield J, Franchi L, Taraporewala ZF, Miller D, Patton JT, Inohara N, et al. 2006. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem 281: 36560-36568.
97. Kastner DL, Aksentijevich I, Goldbach-Mansky R. 2010. Autoinflammatory disease reloaded: A clinical perspective. Cell 140: 784-790.
98. Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, Newton K, Qu Y, Liu J, Heldens S, et al. 2011a. Non-canonical inflammasome activation targets cas-pase-11. Nature 479: 117-121.
99. Kayagaki N, Warming S, Lamkanfi M, Walle LV, Louie S, Dong J, Newton K, Qu Y, Liu J, Heldens S. 2011b. Non-canonical inflammasome activation targets caspase-11. Nature 479: 117-121.
100. Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S, Miyake K, Zhang J, Lee WP, Mus-zynski A, et al. 2013. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341: 1246-1249.
101. Kebaier C, Chamberland RR, Allen IC, Gao X, Broglie PM, Hall JD, Jania C, Doerschuk CM, Tilley SL, Duncan JA. 2012. Staphylococcus aureus a-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome. J Infect Dis 205: 807-817.
102. Kim S, Bauernfeind F, Ablasser A, Hartmann G, Fitzgerald KA, Latz E, Hornung V. 2010. Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome. Eur J Immunol 40: 1545-1551.
103. Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M. 2003. Lack of inter-leukin-1 b decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 23: 656-660.
104. Kistowska M, Gehrke S, Jankovic D, Kerl K, Fettelschoss A, Feldmeyer L, Fenini G, Kolios A, Navarini A, Gancevi-ciene R, et al. 2014. IL-1 b drives inflammatory responses to Propionibacterium acnes in vitro and in vivo. J Invest Dermatol 134: 677-685.
105. Kofoed EM, Vance RE. 2011. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 477: 592-595.
106. Komune N, Ichinohe T, Ito M, Yanagi Y. 2011. Measles virus V protein inhibits NLRP3 inflammasome-mediated in-terleukin-1b secretion. J Virol 85: 13019-13026.
107. Kool M, Petrilli V, De Smedt T, Rolaz A, Hammad H, van Nimwegen M, Bergen IM, Castillo R, Lambrecht BN, Tschopp J. 2008. Cutting edge: Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol 181: 3755-3759.
108. Kovarova M, Hesker PR, Jania L, Nguyen M, Snouwaert JN, Xiang Z, Lommatzsch SE, Huang MT, Ting JP, Koller BH. 2012. NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice. J Immunol 189: 2006-2016.
109. Kummer JA, Broekhuizen R, Everett H, Agostini L, Kuijk L, Martinon F, van Bruggen R, Tschopp J. 2007. Inflamma-some components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histo-chem Cytochem 55: 443-452.
110. Lamkanfi M, Dixit VM. 2012. Inflammasomes and their roles in health and disease. Ann Rev Cell Dev Biol 28: 137-161.
111. Lamkanfi M, Amer A, Kanneganti TD, Munoz-Planillo R, Chen G, Vandenabeele P, Fortier A, Gros P, Nunez G. 2007. The Nod-like receptor family member Naip5/ Birc1e restricts Legionella pneumophila growth independently of caspase-1 activation. J Immunol 178: 8022-8027.
112. Lara-Tejero M, Sutterwala FS, Ogura Y, Grant EP, Bertin J, Coyle AJ, Flavell R., Galan JE. 2006. Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis. J Exp Med 203: 1407-1412.
113. Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY. 2007. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. NEngl J Med 356: 1517-1526.
114. Latz E. 2010. NOX-free inflammasome activation. Blood 116: 1393-1394.
115. Latz E, Xiao TS, Stutz A. 2013. Activation and regulation of the inflammasomes. Nat Rev Immunol 13: 397-411.
116. Lech M, Avila-Ferrufino A, Skuginna V, Susanti HE, Anders HJ. 2010. Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice. Int Immunol 22: 717-728.
117. Lee GS, Subramanian N, Kim AI, Aksentijevich I, Goldbach-Mansky R, Sacks DB, Germain RN, Kastner DL, Chae JJ. 2012. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492: 123-127.
118. Lerner AG, Upton JP, Praveen PV, Ghosh R, Nakagawa Y, Igbaria A, Shen S, Nguyen V, Backes BJ, Heiman M, et al. 2012. IRE1a induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab 16: 250-264.
119. Levandowski CB, Mailloux CM, Ferrara TM, Gowan K, Ben S, Jin Y, McFann KK, Holland PJ, Fain PR, Dinarello CA, et al. 2013. NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1 b processing via the NLRP1 inflammasome. Proc Natl Acad Sci 110: 2952-2956.
120. Levinsohn JL, Newman ZL, Hellmich KA, Fattah R, Getz MA, Liu S, Sastalla I, Leppla SH, Moayeri M. 2012. Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome. PLoS Pathog 8: e1002638.
121. Li H, Nookala S, Re F. 2007. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1b and IL-18 release. J Immunol 178: 5271-5276.
122. Li H, Willingham SB, Ting JP, Re F. 2008. Cutting edge: Inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol 181: 17-21.
123. Li H, Ambade A, Re F. 2009. Cutting edge: Necrosis activates the NLRP3 inflammasome. J Immunol 183: 1528-1532.
124. Liu Z, Zaki MH, Vogel P, Gurung P, Finlay BB, Deng W, Lamkanfi M, Kanneganti T.-D. 2012a. Role of inflamma-somes in host defense against Citrobacter rodentium infection. J Biol Chem 287: 16955-16964.
125. Liu Z, Zaki MH, Vogel P, Gurung P, Finlay BB, Deng W, Lamkanfi M, Kanneganti TD. 2012b. Role of inflamma-somes in host defense against Citrobacter rodentium infection. J Biol Chem 287: 16955-16964.
126. Magitta NF, Boe Wolff AS, Johansson S, Skinningsrud B, Lie BA, Myhr KM, Undlien DE, Joner G, Njolstad PR, Kvien TK, et al. 2009. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun 10: 120-124.
127. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP, Roose-Girma M, Erickson S, Dixit VM. 2004. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430: 213-218.
128. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232.
129. Martinon F, Burns K, Tschopp J. 2002. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of pro-IL-b. Mol Cell 10: 417-426.
130. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241.
131. Masters SL, O'Neill LA. 2011. Disease-associated amyloid and misfolded protein aggregates activate the inflamma some. Trends Mol Med 17: 276-282.
132. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, et al. 2010. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1b in type 2 diabetes. Nat Immunol 11: 897-904.
133. McAuley JL, Tate MD, MacKenzie-Kludas CJ, Pinar A, Zeng W, Stutz A, Latz E, Brown LE, Mansell A. 2013. Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease. PLoS Pathog 9: e1003392.
134. McKee AS, Munks MW, MacLeod MK, Fleenor CJ, Van Rooijen N, Kappler JW, Marrack P. 2009. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol 183: 4403-4414.
135. McNeela EA, Burke A, Neill DR, Baxter C, Fernandes VE, Ferreira D, Smeaton S, El-Rachkidy R, McLoughlin RM, Mori A, et al. 2010. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 6: e1001191.
136. Meissner F, Seger RA, Moshous D, Fischer A, Reichenbach J, Zychlinsky A. 2010a. Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood 116: 1570-1573.
137. Meissner TB, Li A, Biswas A, Lee KH, Liu YJ, Bayir E, Ili-opoulos D, van den Elsen PJ, Kobayashi KS. 2010b. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc Natl Acad Sci 107:13794-13799.
138. Meixenberger K, Pache F, Eitel J, Schmeck B, Hippenstiel S, Slevogt H, N'Guessan P, Witzenrath M, Netea MG, Chakraborty T, et al. 2010. Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1 b, depending on listeriolysin O and NLRP3. JImmunol 184: 922-930.
139. Meng G, Zhang F, Fuss I, Kitani A, Strober W. 2009. A mutation in the Nlrp3 gene causing inflammasome hy-peractivation potentiates Th17 cell-dominant immune responses. Immunity 30: 860-874.
140. Menu P, Pellegrin M, Aubert JF, Bouzourene K, Tardivel A, Mazzolai L, Tschopp J. 2011. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome. Cell Death Dis 2: e137.
141. Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, Miller SI, Aderem A. 2006. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1b via Ipaf. NatImmunol 7: 569-575.
142. Miao EA, Ernst RK, Dors M, Mao DP, Aderem A. 2008. Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc Natl Acad Sci 105: 2562-2567.
143. Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A, Warren SE, Wewers MD, Aderem A. 2010a. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 11: 1136-1142.
144. Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A, Warren SE, Wewers MD, Aderem A. 2010b. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 11: 1136-1142.
145. Miao EA, Mao DP, Yudkovsky N, Bonneau R, Lorang CG, Warren SE, Leaf IA, Aderem A. 2010c. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci 107: 3076-3080.
146. Miao EA, Rajan JV, Aderem A. 2011. Caspase-1-induced pyroptotic cell death. Immunol Rev 243: 206-214.
147. Monroe KM, Yang Z, Johnson JR, Geng X, Doitsh G, Krogan NJ, Greene WC. 2014. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 343: 428-432.
148. Munoz-Planillo R, Kuffa P, Martinez-Colon G, Smith BL, Rajendiran TM, Nunez G. 2013. K+efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38: 1142-1153.
149. Murakami T, Ockinger J, Yu J, Byles V, McColl A, Hofer AM, Horng T. 2012. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci 109: 11282-11287.
150. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim HP, et al. 2011. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12: 222-230.
151. Newman ZL, Leppla SH, Moayeri M. 2009. CA-074Me protection against anthrax lethal toxin. Infect Immun 77: 4327-4336.
152. Ng J, Hirota SA, Gross O, Li Y, Ulke-Lemee A, Potentier MS, Schenck LP, Vilaysane A, Seamone ME, Feng H, et al. Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome. Gastroenterology 139: 542-552.
153. Nordlander S, Pott J, Maloy KJ. 2013. NLRC4 expression in intestinal epithelial cells mediates protection against an enteric pathogen. Mucosal Immunol 7: 775-785.
154. Normand S, Delanoye-Crespin A, Bressenot A, Huot L, Grandjean T, Peyrin-Biroulet L, Lemoine Y, Hot D, Cha-maillard M. 2011. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci 108: 9601-9606.
155. Nour AM, Reichelt M, Ku CC, Ho MY, Heineman TC, Arvin AM. 2011. Varicella-zoster virus infection triggers formation of an interleukin-1 b (IL-1b)-processing inflammasome complex. J Biol Chem 286: 17921-17933.
156. Onoyama S, Ihara K, Yamaguchi Y, Ikeda K, Yamaguchi K, Yamamura K, Hoshina T, Mizuno Y, Hara T. 2012. Genetic susceptibility to Kawasaki disease: Analysis of pattern recognition receptor genes. Hum Immunol 73: 654-660.
157. Oslowski CM, Hara T, O'Sullivan-Murphy B, Kanekura K, Lu S, Hara M, Ishigaki S, Zhu LJ, Hayashi E, Hui ST, et al. 2012. Thioredoxin-interacting protein mediates ER stress-induced b-cell death through initiation of the inflammasome. CellMetab 16: 265-273.
158. Palm NW, Medzhitov R. 2013. Role of the inflammasome in defense against venoms. Proc Natl Acad Sci 110: 1809-1814.
159. Petrilli V, Papin S, Dostert C, Mayor A, Martinon F, Tschopp J. 2007. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14: 1583-1589.
160. Poeck H, Bscheider M, Gross O, Finger K, Roth S, Rebsamen M, Hannesschlager N, Schlee M, Rothenfusser S, Barchet W, et al. 2010. Recognition of RNAvirus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 b production. Nat Immunol 11: 63-69.
161. Pontillo A, Brandao L, Guimaraes R, Segat L, Araujo J, Cro-vella S. 2010. Two SNPs in NLRP3 gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast Brazil. Autoimmu-nity 43: 583-589.
162. Pontillo A, Vendramin A, Catamo E, Fabris A, Crovella S. The missense variation Q705K in CIAS1 /NALP3/ NLRP3 gene and an NLRP1 haplotype are associated with celiac disease. Am JGastroenterol 106: 539-544.
163. Pontillo A, Catamo E, Arosio B, Mari D, Crovella S. 2012a. NALP1 /NLRP1 genetic variants are associated with Alzheimer disease. Alzheimer Dis Assoc Disord 26: 277-281.
164. Pontillo A, Girardelli M, Kamada AJ, Pancotto JA, Donadi EA, Crovella S, Sandrin-Garcia P. 2012b. Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity 45: 271-278.
165. Pothlichet J, Meunier I, Davis BK, Ting JP, Skamene E, von Messling V, Vidal SM. 2013. Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza Avirus infected cells. PLoS Pathog 9: e1003256.
166. Qu Y, Misaghi S, Izrael-Tomasevic A, Newton K, Gilmour LL, Lamkanfi M, Louie S, Kayagaki N, Liu J, Komuves L, et al. 2012. Phosphorylation of NLRC4 is critical for in-flammasome activation. Nature 490: 539-542.
167. Rajamaki K, Lappalainen J, Oorni K, Valimaki E, Matikai-nen S, Kovanen PT, Eklund KK. 2010. Cholesterol crystals activate the NLRP3 inflammasome in human macro-phages: A novel link between cholesterol metabolism and inflammation. PLoS ONE 5: e11765.
168. Rajan JV, Rodriguez D, Miao EA, Aderem A. 2011. The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection. J Virol 85: 4167-4172.
169. Rathinam VA, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L, Vanaja SK, Monks BG, Ganesan S, Latz E, et al. 2010. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNAviruses. Nat Immunol 11: 395-402.
170. Raupach B, Peuschel S-K, Monack DM, Zychlinsky A. 2006. Caspase-1-mediated activation of interleukin-1 b (IL-1 b) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar typhimurium infection. Infect Immun 74: 4922-4926.
171. Reed JC, Doctor K, Rojas A, Zapata JM, Stehlik C, Fiorentino L, Damiano J, Roth W, Matsuzawa S, Newman R, et al. 2003. Comparative analysis of apoptosis and inflammation genes of mice and humans. Genome Res 13: 1376-1388.
172. Riteau N, Gasse P, Fauconnier L, Gombault A, Couegnat M, Fick L, Kanellopoulos J, Quesniaux VF, Marchand-Adam S, Crestani B, et al. 2010. Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am JRespir Crit Care Med 182: 774-783.
173. Rock KL, Kataoka H, Lai JJ. 2013. Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol 9: 13-23.
174. Rossol M, Pierer M, Raulien N, Quandt D, Meusch U, Rothe K, Schubert K, Schoneberg T, Schaefer M, Krugel U, et al. 2012. Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors. Nat Commun 3: 1329.
175. Rotta Detto Loria J, Rohmann K, Droemann D, Kujath P, Rupp J, Goldmann T, Dalhoff K. 2013. Nontypeable Haemophilus influenzae infection upregulates the NLRP3 inflammasome and leads to caspase-1-dependent secretion of interleukin-1 b—A possible pathway of exacerbations in COPD. PLoS ONE 8: e66818.
176. Saiga H, Kitada S, Shimada Y, Kamiyama N, Okuyama M, Makino M, Yamamoto M, Takeda K. 2012. Critical role of AIM2 in Mycobacterium tuberculosis infection. IntImmunol 24: 637-644.
177. Sauer JD, Witte CE, Zemansky J, Hanson B, Lauer P, Portnoy DA. 2010. Listeria monocytogenes triggers AIM2-mediat-ed pyroptosis upon infrequent bacteriolysis in the mac-rophage cytosol. Cell Host Microbe 7: 412-419.
178. Sauer JD, Pereyre S, Archer KA, Burke TP, Hanson B, Lauer P, Portnoy DA. 2011. Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunity. Proc Natl Acad Sci 108: 12419-12424.
179. Schattgen SA, Fitzgerald KA. 2011. The PYHIN protein family as mediators of host defenses. Immunol Rev 243:109-118.
180. Schneider M, Zimmermann AG, Roberts RA, Zhang L, Swanson KV, Wen H, Davis BK, Allen IC, Holl EK, Ye Z, et al. 2012. The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-kB. Nat Immunol 13: 823-831.
181. Schroder K, Tschopp J. 2010. The inflammasomes. Cell 140: 821-832.
182. Segovia J, Sabbah A, Mgbemena V, Tsai SY, Chang TH, Ber-ton MT, Morris IR, Allen IC, Ting JP, Bose S. 2012. TLR2/ MyD88/NF-kB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS ONE 7: e29695.
183. Sheedy FJ, Moore KJ. 2013. IL-1 signaling in atherosclerosis: Sibling rivalry. Nat Immunol 14: 1030-1032.
184. Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB, Becker CE, Ediriweera HN, Mullick AE, Golenbock DT, et al. 2013. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nu-cleation ofsoluble ligands into particulate ligands in sterile inflammation. Nat Immunol 14: 812-820.
185. Shi F, Yang L, Kouadir M, Yang Y, Wang J, Zhou X, Yin X, Zhao D. 2012. The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation. J Neuroinflammation 9: 73.
186. Shimada K, Crother TR, Karlin J, Chen S, Chiba N, Ramanujan VK, Vergnes L, Ojcius DM, Arditi M. 2011. Caspase-1 dependent IL-1 b secretion is critical for host defense in a mouse model of Chlamydia pneumoniae lung infection. PLoS ONE 6: e21477.
187. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, et al. 2012. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36:401-414
188. Shio MT, Eisenbarth SC, Savaria M, Vinet AF, Bellemare MJ, Harder KW, Sutterwala FS, Bohle DS, Descoteaux A, Fla-vell RA, et al. 2009. Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog 5: e1000559.
189. So A, De Smedt T, Revaz S, Tschopp J. 2007. A pilot studyof IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 9: R28.
190. Song-Zhao GX, Srinivasan N, Pott J, Baban D, Frankel G, Maloy KJ. 2013. Nlrp3 activation in the intestinal epithelium protects against a mucosal pathogen. Mucosal Immunol 7: 763-774.
191. Stienstra R, Joosten LA, Koenen T, van Tits B, van Diepen JA, van den Berg SA, Rensen PC, Voshol PJ, Fantuzzi G, Hij-mans A, et al. 2010. The inflammasome-mediated cas-pase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metabol 12: 593-605.
192. Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veer-donk FL, Perera D, Neale GA, Hooiveld GJ, Hijmans A, Vroegrijk I, et al. 2011. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci 108: 15324-15329.
193. Strowig T, Henao-Mejia J, Elinav E, Flavell R. 2012. Inflam-masomes in health and disease. Nature 481: 278-286.
194. Sui J, Li H, Fang Y, Liu Y, Li M, Zhong B, Yang F, Zou Q, Wu Y. 2012. NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in Han Chinese. Arthritis Rheum 64: 647-654.
195. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lich-tenberger GS, Grant EP, Bertin J, Coyle AJ, Galan JE, Askenase PW, et al. 2006. Critical role for NALP3/CIAS1 /Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24: 317-327.
196. Sutterwala FS, Mijares LA, Li L, Ogura Y, Kazmierczak BI, Flavell RA. 2007. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J Exp Med 204: 3235-3245.
197. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune en-cephalomyelitis. J Exp Med 203: 1685-1691.
198. Suzuki T, Franchi L, Toma C, Ashida H, Ogawa M, Yoshi-kawa Y, Mimuro H, Inohara N, Sasakawa C, Nunez G. Differential regulation of caspase-1 activation, py-roptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog 3: e111.
199. Thomas PG, Dash P, Aldridge JR Jr., Ellebedy AH, Reynolds C, Funk AJ, Martin WJ, Lamkanfi M, Webby RJ, Boyd KL, et al. 2009. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza Avirus via the regulation of caspase-1. Immunity 30: 566-575.
200. Ting JP, Lovering RC, Alnemri ES, Bertin J, Boss JM, Davis BK, Flavell R., Girardin SE, Godzik A, Harton JA, et al. The NLR gene family: A standard nomenclature. Immunity 28: 285-287.
201. Toma C, Higa N, Koizumi Y, Nakasone N, Ogura Y, McCoy AJ, Franchi L, Uematsu S, Sagara J, Taniguchi S, et al. 2010. Pathogenic Vibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-binding oligomeri-zation domain-mediated NF-kB signaling. J Immunol 184: 5287-5297.
202. Tomalka J, Ganesan S, Azodi E, Patel K, Majmudar P, Hall BA, Fitzgerald KA, Hise AG. 2011. A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathog 7: e1002379.
203. Triantafilou K, Kar S, Vakakis E, Kotecha S, Triantafilou M. 2013a. Human respiratory syncytial virus viroporin SH: A viral recognition pathway used by the host to signal inflammasome activation. Thorax 68: 66-75.
204. Triantafilou K, Kar S, van Kuppeveld FJ, Triantafilou M. 2013b. Rhinovirus-induced calcium flux triggers NLRP3 and NLRC5 activation in bronchial cells. Am JRespir Cell Mol Biol 49: 923-934.
205. Tsuchiya K, Hara H, Kawamura I, Nomura T, Yamamoto T, Daim S, Dewamitta SR, Shen Y, Fang R, Mitsuyama M. 2010. Involvement of absent in melanoma 2 in inflam-masome activation in macrophages infected with Listeria monocytogenes. J Immunol 185: 1186-1195.
206. Tsuji NM, Tsutsui H, Seki E, Kuida K, Okamura H, Naka-nishi K, Flavell RA. 2004. Roles of caspase-1 in Listeria infection in mice. Int Immunol 16: 335-343.
207. Usui F, Shirasuna K, Kimura H, Tatsumi K, Kawashima A, Karasawa T, Hida S, Sagara J, Taniguchi S, Takahashi M. 2012. Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice. Biochem Biophys Res Commun 425: 162-168.
208. van Bruggen R, Koker MY, Jansen M, van Houdt M, Roos D, Kuijpers TW, van den Berg TK. 2010. Human NLRP3 inflammasome activation is Nox1-4 independent. Blood 115: 5398-5400.
209. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD. 2011. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17: 179-188.
210. Vladimer GI, Weng D, Paquette SW, Vanaja SK, Rathinam VA Aune MH, Conlon JE, Burbage JJ, Proulx MK, Liu Q, et al. 2012. The NLRP12 inflammasome recognizes Yersinia pestis. Immunity 37: 96-107.
211. von Moltke J, Trinidad NJ, Moayeri M, Kintzer AF, Wang SB, van Rooijen N, Brown CR, Krantz BA, Leppla SH, Gro-nert K, et al. 2012. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 490: 107-111.
212. Walsh JG, Muruve DA, Power C. 2014. Inflammasomes in the CNS. Nat Rev Neurosci 15: 84-97.
213. Wang L, Manji GA, Grenier JM, Al-Garawi A, Merriam S, Lora JM, Geddes BJ, Briskin M, DiStefano PS, Bertin J. 2002. PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kB and caspase-1-dependent cytokine processing. J Biol Chem 277: 29874-29880.
214. Warren SE, Mao DP, Rodriguez AE, Miao EA, Aderem A. 2008. Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection. J Immunol 180: 7558-7564.
215. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ, Ting JP. 2011. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12: 408-415.
216. Wickliffe KE, Leppla SH, Moayeri M. 2008. Anthrax lethal toxin-induced inflammasome formation and caspase-1 activation are late events dependent on ion fluxes and the proteasome. Cell Microbiol 10: 332-343.
217. Willingham SB, Allen IC, Bergstralh DT, Brickey WJ, Huang MT, Taxman DJ, Duncan JA, Ting JP. 2009. NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. J Immunol 183: 2008-2015.
218. Wlodarska M, Thaiss CA, Nowarski R, Henao-Mejia J, Zhang JP, Brown EM, Frankel G, Levy M, Katz MN, Phil-brick WM, et al. 2014. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 156: 1045-1059.
219. Wu J, Fernandes-Alnemri T, Alnemri ES. 2010. Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by Listeria monocytogenes. J Clin Immunol 30: 693-702.
220. Zaki MH, Vogel P, Malireddi RK, Body-Malapel M, Anand PK, Bertin J, Green DR, Lamkanfi M, Kanneganti TD. 2011. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell 20: 649-660.
221. Zhang W, Cai Y, Xu W, Yin Z, Gao X, Xiong S. 2013. AIM2 facilitates the apoptotic DNA-induced systemic lupus erythematosus via arbitrating macrophage functional maturation. J Clin Immunol 33: 925-937.
222. Zhang L, Mo J, Swanson KV, Wen H, Petrucelli A, Gregory SM, Zhang Z, Schneider M, Jiang Y, Fitzgerald KA, et al. 2014. NLRC3, a member of the NLR family of proteins, is a negative regulator of innate immune signaling induced by the DNA sensor STING. Immunity 40: 329-341.
223. Zhao Y, Yang J, Shi J, Gong YN, Lu Q, Xu H, Liu L, Shao F. 2011. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477: 596-600.
224. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. 2010. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11: 136-140.
225. Zurawek M, Fichna M, Januszkiewicz-Lewandowska D, Gryczynska M, Fichna P, Nowak J. 2010. A coding variant in NLRP1 is associated with autoimmune Addison's disease. Hum Immunol 71: 530-534.